Study of 68Ga-R10602

Clinical trial NCT06745804 · COMPLETED

Trial details

NCT number: NCT06745804
Sponsor: Radionetics Oncology
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Locoregionally Recurrent Hormone-receptor Positive Breast Cancer Metastatic Hormone Receptor Positive Breast Cancer Hormone Receptor Positive Breast Adenocarcinoma

Start date: 2024-12-10
Primary completion: 2026-05-04
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.